Literature DB >> 31285229

Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in Aspergillus Species Received within a Surveillance Program on Antifungal Resistance in Spain.

Olga Rivero-Menendez1, Juan Carlos Soto-Debran1, Narda Medina1, Jose Lucio1, Emilia Mellado1,2, Ana Alastruey-Izquierdo3,2.   

Abstract

Antifungal resistance is one of the major causes of the increasing mortality rates for fungal infections, especially for those caused by Aspergillus spp. A surveillance program was established in 2014 in the Spanish National Center for Microbiology for tracking resistance in the most prevalent Aspergillus species. A total of 273 samples were included in the study and were initially classified as susceptible or resistant according to EUCAST breakpoints. Several Aspergillus cryptic species were found within the molecularly identified isolates. Cyp51 mutations were characterized for Aspergillus fumigatus, Aspergillus terreus, and Aspergillus flavus sensu stricto strains that were classified as resistant. Three A. fumigatus sensu stricto strains carried the TR34/L98H resistance mechanism, while two harbored G54R substitution and one harbored the TR46/Y121F/T289A mechanism. Seventeen strains had no mutations in cyp51A, with ten of them resistant only to isavuconazole. Three A. terreus sensu stricto strains harbored D344N substitution in cyp51A, one of them combined with M217I, and another carried an A249G novel mutation. Itraconazole-resistant A. flavus sensu stricto strains harbored P220L and H349R alterations in cyp51A and cyp51C, respectively, that need further investigation on their implication in azole resistance.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Aspergilluszzm321990; Cyp51; EUCAST; antifungal resistance; azoles; isavuconazole; itraconazole; posaconazole; surveillance program; voriconazole

Mesh:

Substances:

Year:  2019        PMID: 31285229      PMCID: PMC6709457          DOI: 10.1128/AAC.00865-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  49 in total

1.  Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.

Authors:  Ahmed Bueid; Susan J Howard; Caroline B Moore; Malcolm D Richardson; Elizabeth Harrison; Paul Bowyer; David W Denning
Journal:  J Antimicrob Chemother       Date:  2010-08-20       Impact factor: 5.790

2.  Investigation of Multiple Resistance Mechanisms in Voriconazole-Resistant Aspergillus flavus Clinical Isolates from a Chest Hospital Surveillance in Delhi, India.

Authors:  Cheshta Sharma; Rakesh Kumar; Nitin Kumar; Aradhana Masih; Dinesh Gupta; Anuradha Chowdhary
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

Review 3.  Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients.

Authors:  Livio Pagano; Murat Akova; George Dimopoulos; Raoul Herbrecht; Lubos Drgona; Nicole Blijlevens
Journal:  J Antimicrob Chemother       Date:  2011-01       Impact factor: 5.790

4.  Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence.

Authors:  Maiken Cavling Arendrup; Eleftheria Mavridou; Klaus Leth Mortensen; Eveline Snelders; Niels Frimodt-Møller; Humara Khan; Willem J G Melchers; Paul E Verweij
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

Review 5.  Antifungal susceptibility profile of cryptic species of Aspergillus.

Authors:  Ana Alastruey-Izquierdo; Laura Alcazar-Fuoli; Manuel Cuenca-Estrella
Journal:  Mycopathologia       Date:  2014-06-28       Impact factor: 2.574

6.  Potential basis for amphotericin B resistance in Aspergillus terreus.

Authors:  Gerhard Blum; Susanne Perkhofer; Hubertus Haas; Markus Schrettl; Reinhard Würzner; Manfred P Dierich; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2008-02-11       Impact factor: 5.191

7.  First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States.

Authors:  Nathan P Wiederhold; Veronica Garcia Gil; Felipe Gutierrez; Jonathan R Lindner; Mohammad T Albataineh; Dora I McCarthy; Carmita Sanders; Hongxin Fan; Annette W Fothergill; Deanna A Sutton
Journal:  J Clin Microbiol       Date:  2015-10-21       Impact factor: 5.948

8.  Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.

Authors:  Jochem B Buil; Roger J M Brüggemann; Roeland E Wasmann; Jan Zoll; Jacques F Meis; Willem J G Melchers; Johan W Mouton; Paul E Verweij
Journal:  J Antimicrob Chemother       Date:  2018-01-01       Impact factor: 5.790

Review 9.  Hidden killers: human fungal infections.

Authors:  Gordon D Brown; David W Denning; Neil A R Gow; Stuart M Levitz; Mihai G Netea; Theodore C White
Journal:  Sci Transl Med       Date:  2012-12-19       Impact factor: 17.956

10.  Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009.

Authors:  Jan W M van der Linden; Eveline Snelders; Greetje A Kampinga; Bart J A Rijnders; Eva Mattsson; Yvette J Debets-Ossenkopp; Ed J Kuijper; Frank H Van Tiel; Willem J G Melchers; Paul E Verweij
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

View more
  14 in total

1.  Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.

Authors:  Laís Pontes; Caio Augusto Gualtieri Beraquet; Teppei Arai; Guilherme Leite Pigolli; Luzia Lyra; Akira Watanabe; Maria Luiza Moretti; Angélica Zaninelli Schreiber
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 2.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

Review 3.  Emergence of Triazole Resistance in Aspergillus spp. in Latin America.

Authors:  Daiana Macedo; Florencia Leonardelli; Soledad Gamarra; Guillermo Garcia-Effron
Journal:  Curr Fungal Infect Rep       Date:  2021-05-19

Review 4.  Detecting Azole-Antifungal Resistance in Aspergillus fumigatus by Pyrosequencing.

Authors:  Mireille H van der Torre; Lilyann Novak-Frazer; Riina Rautemaa-Richardson
Journal:  J Fungi (Basel)       Date:  2020-01-10

Review 5.  Sterol 14α-Demethylase Ligand-Binding Pocket-Mediated Acquired and Intrinsic Azole Resistance in Fungal Pathogens.

Authors:  Katharina Rosam; Brian C Monk; Michaela Lackner
Journal:  J Fungi (Basel)       Date:  2020-12-22

6.  Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response.

Authors:  Dionysios Neofytos; Carolina Garcia-Vidal; Frédéric Lamoth; Christoph Lichtenstern; Alessandro Perrella; Jörg Janne Vehreschild
Journal:  BMC Infect Dis       Date:  2021-03-24       Impact factor: 3.090

Review 7.  Updated EUCAST Clinical Breakpoints against Aspergillus, Implications for the Clinical Microbiology Laboratory.

Authors:  Jesús Guinea
Journal:  J Fungi (Basel)       Date:  2020-12-06

8.  Dissection of the Activity of Agricultural Fungicides against Clinical Aspergillus Isolates with and without Environmentally and Medically Induced Azole Resistance.

Authors:  Karin Meinike Jørgensen; Marie Helleberg; Rasmus Krøger Hare; Lise Nistrup Jørgensen; Maiken Cavling Arendrup
Journal:  J Fungi (Basel)       Date:  2021-03-11

9.  PDR Transporter ABC1 Is Involved in the Innate Azole Resistance of the Human Fungal Pathogen Fusarium keratoplasticum.

Authors:  Jasper Elvin James; Erwin Lamping; Jacinta Santhanam; Richard David Cannon
Journal:  Front Microbiol       Date:  2021-06-04       Impact factor: 5.640

10.  Point Mutations in the 14-α Sterol Demethylase Cyp51A or Cyp51C Could Contribute to Azole Resistance in Aspergillus flavus.

Authors:  Jose Lucio; Irene Gonzalez-Jimenez; Olga Rivero-Menendez; Ana Alastruey-Izquierdo; Teresa Pelaez; Laura Alcazar-Fuoli; Emilia Mellado
Journal:  Genes (Basel)       Date:  2020-10-17       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.